Travecta Therapeutics pockets $15m Series A

Philadelphia and Singapore-based Travecta Therapeutics, a biopharmaceutical company, has secured $15 million in Series A financing.

To read this article, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to read this article and more for free.

Share this